Therapeutic antibody development requires large quantities of purified protein samples. The conventional antibody purification process relies on researchers manually handling one chromatography column at a time, conducting repetitive loading, washing, and eluting steps. Now, this painstakingly slow process is undergoing an overhaul. In this webinar brought to you by Tecan, Drew Wassel and Alexandrea Defaria will discuss how their team leverages automation to streamline antibody purification and accelerate their progress toward the next phase of drug development.
Topics to be covered
- Accelerating antibody development using automated purification
- Using automation to rapidly measure antibodies’ essential quality attributes
Thursday, July 27th, 2023 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.
Drew Wassel, PhD
Director of Formulation Development
Senior Process Development Associate